ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

In vitro susceptibility studies with josamycin and erythromycin | JoVE Visualize

Home
Research Domains
Biological Sciences

In vitro susceptibility studies with josamycin and erythromycin

L J Strausbaugh, J A Dilworth, J M Gwaltney

Antimicrobial Agents and Chemotherapy|March 1, 1976

Related Experiment Videos

View abstract on PubMed

Summary

Josamycin and erythromycin exhibit comparable in vitro antibacterial activity. Erythromycin demonstrated slightly higher potency by weight against the tested bacterial species, but both macrolides offered a similar spectrum of action.

Area of Science:

Microbiology
Pharmacology
Infectious Diseases

Background:

Macrolide antibiotics are crucial in treating bacterial infections.
Josamycin and erythromycin are commonly used macrolides.
Understanding their comparative efficacy is important for clinical application.

Purpose of the Study:

To compare the in vitro antibacterial activity of josamycin and erythromycin.
To determine the relative potency and spectrum of activity of these two macrolides.

Main Methods:

In vitro susceptibility testing was performed.
Five different bacterial species were utilized.
Antibacterial activity was assessed by comparing the agents' effects.

Main Results:

Both josamycin and erythromycin demonstrated activity against the five bacterial species.
Erythromycin showed slightly greater activity on a weight basis compared to josamycin.
The overall range of antibacterial activity was similar for both drugs.

Conclusions:

Josamycin and erythromycin possess comparable in vitro antibacterial profiles.
Erythromycin may be slightly more potent than josamycin by weight.
Both macrolides offer a similar spectrum of activity, suggesting interchangeable roles in certain clinical scenarios.

Related Experiment Videos

Related Concept Videos

Microbial Ecology

In Vitro Susceptibility Studies With Josamycin And Erythromycin